We are live on
!
Find out more
RCAMU
Rothschild & Co Asset Management US Portfolio holdings
AUM
$6.58B
1-Year Est. Return
4.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.91%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
–
AUM
$4.86B
AUM Growth
+$372M
(+8.3%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
14.23%
Holding
386
New
26
Increased
110
Reduced
206
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$38.7M |
| 2 |
Cisco
CSCO
|
+$37.1M |
| 3 |
Parker-Hannifin
PH
|
+$31.7M |
| 4 |
PepsiCo
PEP
|
+$30.4M |
| 5 |
AT&T
T
|
+$25.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$30.2M |
| 2 |
Norfolk Southern
NSC
|
+$22.6M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$21.6M |
| 4 |
BorgWarner
BWA
|
+$19.2M |
| 5 |
STSA
STERLING FINL CORP (WA) COM NEW
STSA
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.44% |
| 2 | Financials | 15.52% |
| 3 | Technology | 13.68% |
| 4 | Healthcare | 11.91% |
| 5 | Consumer Discretionary | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
NNN REIT
NNN
$8.34B
| $8.28M | 0.17% |
222,517
-1,929
| -0.9% | -$67.8K |
|
|
AWH
202
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $8.27M | 0.17% |
217,489
-1,622
| -0.7% | -$59.1K |
|
203
Ubiquiti
UI
$34.2B
| $8.27M | 0.17% |
182,935
-4,535
| -2% | -$178K |
|
|
SIRO
204
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $8.24M | 0.17% |
99,930
-1,140
| -1% | -$86.8K |
|
205
United Therapeutics
UTHR
$21.5B
| $8.21M | 0.17% |
92,776
-429
| -0.5% | -$41.3K |
|
|
FRC
206
DELISTED
First Republic Bank
FRC
| $8.17M | 0.17% |
148,574
-467
| -0.3% | -$24.5K |
|
207
Maximus
MMS
$3.08B
| $8.17M | 0.17% |
189,891
-480
| -0.3% | -$20.6K |
|
|
CATM
208
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $8.13M | 0.17% |
238,680
-1,988
| -0.8% | -$66.4K |
|
|
KATE
209
DELISTED
Kate Spade & Company
KATE
| $8.13M | 0.17% |
213,033
-65,248
| -23% | -$2.34M |
|
210
CNO Financial Group
CNO
$5.14B
| $8M | 0.16% |
449,557
-91,247
| -17% | -$1.56M |
|
211
CONMED
CNMD
$1.38B
| $7.91M | 0.16% |
179,207
-3,617
| -2% | -$164K |
|
|
ADVS
212
DELISTED
Advent Software Inc
ADVS
| $7.91M | 0.16% |
242,887
+53,261
| +28% | +$1.58M |
|
|
BPFH
213
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $7.86M | 0.16% |
584,639
-3,194
| -0.5% | -$40.9K |
|
|
SF
214
Stifel
SF
$11.6B
| $7.84M | 0.16% |
+372,686
| New | +$7.68M |
|
|
EGN
215
DELISTED
Energen
EGN
| $7.82M | 0.16% |
87,923
-892
| -1% | -$75.1K |
|
216
Interparfums
IPAR
$3.5B
| $7.75M | 0.16% |
262,223
-2,399
| -0.9% | -$76.6K |
|
|
MZTI
217
The Marzetti Company
MZTI
$2.76B
| $7.73M | 0.16% |
81,192
-1,197
| -1% | -$111K |
|
|
MRC
218
DELISTED
MRC Global
MRC
| $7.72M | 0.16% |
272,787
-5,624
| -2% | -$160K |
|
219
Insperity
NSP
$1.94B
| $7.68M | 0.16% |
465,248
-12,328
| -3% | -$196K |
|
220
Procter & Gamble
PG
$342B
| $7.61M | 0.16% |
96,883
-2,500
| -3% | -$202K |
|
|
JAH
221
DELISTED
JARDEN CORPORATION
JAH
| $7.56M | 0.16% |
191,177
-3,283
| -2% | -$125K |
|
222
IQVIA
IQV
$44.6B
| $7.55M | 0.16% |
+141,701
| New | +$7.15M |
|
223
Vishay Intertechnology
VSH
$4.81B
| $7.52M | 0.15% |
485,317
-2,494
| -0.5% | -$37K |
|
224
Raymond James Financial
RJF
$32.4B
| $7.52M | 0.15% |
222,224
-1,822
| -0.8% | -$60.8K |
|
|
PLCM
225
DELISTED
POLYCOM INC
PLCM
| $7.45M | 0.15% |
+594,370
| New | +$7.54M |
|
Similar funds
GG
AIM
AAM
PG
ZCA
GJIC
SBL
TFS
Rothschild & Co Asset Management US's Q2 2014 Portfolio in Review
As of Q2 2014, Rothschild & Co Asset Management US held 386 positions worth $4.86B, up 8.3% from $4.49B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Rothschild & Co Asset Management US deployed $181M of net new capital in Q2 2014, opening 26 new positions and adding to 110 existing holdings. Its largest new stake was Merck: 710,112 shares worth $39.2M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was St Jude Medical, an estimated $30.2M trimmed.
- Rothschild & Co Asset Management US's largest Q2 2014 buy was Merck: 710,112 shares worth $39.2M.
- Rothschild & Co Asset Management US added most to Cisco in Q2 2014, an estimated $37.1M increase.
- Rothschild & Co Asset Management US's biggest Q2 2014 reduction was St Jude Medical, cutting an estimated $30.2M.
- Rothschild & Co Asset Management US fully exited Norfolk Southern in Q2 2014, selling an estimated $22.6M.
- Rothschild & Co Asset Management US's ten largest holdings make up 14% of its $4.86B portfolio in Q2 2014.
- Rothschild & Co Asset Management US opened 26 new positions and closed 37 in Q2 2014.
- Rothschild & Co Asset Management US's portfolio value rose 8.3% quarter-over-quarter to $4.86B.
Based on Rothschild & Co Asset Management US's 13F filing for Q2 2014, filed 14 Aug 2014.